Filing Details
- Accession Number:
- 0001225208-18-001052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-16 17:12:57
- Reporting Period:
- 2018-01-12
- Accepted Time:
- 2018-01-16 17:12:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1168014 | M Mirian Weir Graddick | Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033 | Exe V-P, Hr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-12 | 5,000 | $58.00 | 101,484 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-16 | 52,000 | $44.30 | 153,484 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 8,000 | $61.63 | 145,484 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 52,000 | $61.63 | 93,484 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-01-16 | 52,000 | $0.00 | 52,000 | $44.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-02-28 | 2018-02-28 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Holdings include shares acquired in dividend reinvestment transactions.
- The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
Billionaire Hedge Funds
